Literature DB >> 21396808

Optimising stereotactic body radiotherapy for non-small cell lung cancer with volumetric intensity-modulated arc therapy--a planning study.

J Brock1, J Bedford, M Partridge, F McDonald, S Ashley, H A McNair, M Brada.   

Abstract

AIMS: The potential advantages of stereotactic body radiotherapy (SBRT) for early stage non-small cell lung cancer (NSCLC) over conventional fractionated radiotherapy include a higher biological effective dose, a reduction in accelerated repopulation, greater patient convenience and reduced demand on radiotherapy resources. Before introducing SBRT in our department, a review of planning and delivery was undertaken, starting with an assessment of optimum beam number and arrangement.
MATERIALS AND METHODS: Radiotherapy planning computed tomography scans for five patients previously treated for T1 peripheral NSCLC were selected. In each the contoured tumour had planning target volume (PTV) margins of 1cm in all directions. Forward-planned three-field coplanar and non-coplanar plans and a seven-field coplanar plan were produced and optimised. In-house inverse-planning software (AutoBeam) was used to generate three-, five-, seven- and nine-field coplanar and non-coplanar plans and two volumetric intensity-modulated arc therapy (VMAT) plans. The resulting V(20), V(11), PTV(90), PTV(95) and mean lung dose were compared.
RESULTS: Analysis of variance showed non-coplanar plans to have lower V(11) and higher PTV(90) and PTV(95) than coplanar plans. VMAT showed equivalent V(20) and target coverage when compared with the best non-coplanar plans, but with a faster delivery time (2min 8s versus 12min 40s).
CONCLUSIONS: Inverse-planned five-field non-coplanar plans and VMAT improve target coverage while minimising the higher dose to normal lung tissue for SBRT of NSCLC compared with coplanar beam arrangements. VMAT is preferable because of significantly shorter treatment delivery times.
Copyright © 2011 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21396808     DOI: 10.1016/j.clon.2011.02.003

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  12 in total

Review 1.  Volumetric modulated arc therapy: a review of current literature and clinical use in practice.

Authors:  M Teoh; C H Clark; K Wood; S Whitaker; A Nisbet
Journal:  Br J Radiol       Date:  2011-11       Impact factor: 3.039

2.  Assessment of the robustness of volumetric-modulated arc therapy for lung radiotherapy.

Authors:  K Edmunds; J Bedford
Journal:  Br J Radiol       Date:  2013-02-07       Impact factor: 3.039

3.  Lung stereotactic body radiotherapy using a coplanar versus a non-coplanar beam technique: a comparison of clinical outcomes.

Authors:  Christopher L Hallemeier; Michael C Stauder; Robert C Miller; Yolanda I Garces; Robert L Foote; Jann N Sarkaria; Heather J Bauer; Charles S Mayo; Kenneth R Olivier
Journal:  J Radiosurg SBRT       Date:  2013

4.  Predictive factors for acute radiation pneumonitis in postoperative intensity modulated radiation therapy and volumetric modulated arc therapy of esophageal cancer.

Authors:  Yaqin Zhao; Lu Chen; Shu Zhang; Qiang Wu; Xiaoqin Jiang; Hong Zhu; Jin Wang; Zhiping Li; Yong Xu; Ying Jie Zhang; Sen Bai; Feng Xu
Journal:  Thorac Cancer       Date:  2015-01-07       Impact factor: 3.500

5.  Lung SBRT: dosimetric and delivery comparison of RapidArc, TomoTherapy, and IMR.

Authors:  Ashleigh Weyh; Andre Konski; Adrian Nalichowski; Jordan Maier; Danielle Lack
Journal:  J Appl Clin Med Phys       Date:  2013-07-08       Impact factor: 2.102

6.  Dosimetric effects of immobilization devices on SABR for lung cancer using VMAT technique.

Authors:  Jong In Park; Sung-Joon Ye; Hak Jae Kim; Jong Min Park
Journal:  J Appl Clin Med Phys       Date:  2015-01-08       Impact factor: 2.102

Review 7.  Clinical utility of RapidArc™ radiotherapy technology.

Authors:  Erminia Infusino
Journal:  Cancer Manag Res       Date:  2015-11-12       Impact factor: 3.989

8.  Improving Delivery Accuracy of Stereotactic Body Radiotherapy to a Moving Tumor Using Simplified Volumetric Modulated Arc Therapy.

Authors:  Young Eun Ko; Byungchul Cho; Su Ssan Kim; Si Yeol Song; Eun Kyung Choi; Seung Do Ahn; Byongyong Yi
Journal:  PLoS One       Date:  2016-06-22       Impact factor: 3.240

9.  A dosimetric evaluation of VMAT for the treatment of non-small cell lung cancer.

Authors:  Caitlin E Merrow; Iris Z Wang; Matthew B Podgorsak
Journal:  J Appl Clin Med Phys       Date:  2012-09-01       Impact factor: 2.102

10.  A Dose Falloff Gradient Study in RapidArc Planning of Lung Stereotactic Body Radiation Therapy.

Authors:  Ganesh Narayanasamy; Dharmin Desai; Sanjay Maraboyina; Jose Penagaricano; Robert Zwicker; Ellis Lee Johnson
Journal:  J Med Phys       Date:  2018 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.